Comparison of Various Prosthetic Foot-Ankle Mechanisms
Launched by MASSACHUSETTS INSTITUTE OF TECHNOLOGY · Jul 19, 2023
Trial Information
Current as of November 11, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
MIT is running a study to compare several foot-and-ankle prosthetic devices for people who have had one below-knee amputation. About 10 adults (ages 18–65) who are fairly mobile (Medicare levels K3 or K4) will try five devices—three passive (non-powered) and two powered—while researchers measure how they walk. The goal is to see which device people prefer for level walking, climbing stairs, and walking on a gentle slope, and to compare how each device changes walking patterns.
If you participate, you’ll complete two lab sessions totaling about 8 hours. A prosthetist will fit and align the devices, and you’ll practice with them before data are collected. Researchers will use cameras and force sensors to analyze your gait and you’ll answer short questionnaires after trying the devices. All five devices will be tested in random order. Some devices are experimental or not yet fully approved. The study began in 2023 and is currently enrolling by invitation, with completion expected by the end of 2025.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Person with unilateral transtibial amputation
- • K3 or K4 Medicare mobility rating
- • Ages 18-65
- Exclusion Criteria:
- • Below K3 Medicare mobility rating
- • Outside of age range (liability and safety reasons)
About Massachusetts Institute Of Technology
The Massachusetts Institute of Technology (MIT) is a prestigious research university located in Cambridge, Massachusetts, renowned for its cutting-edge contributions to science, technology, and engineering. As a clinical trial sponsor, MIT leverages its interdisciplinary expertise and state-of-the-art facilities to advance medical research and innovation. The institution is committed to fostering collaboration between academic, industry, and clinical partners, aiming to translate groundbreaking research into practical healthcare solutions. MIT's rigorous approach to clinical trials ensures the highest standards of scientific integrity and patient safety, positioning it as a leader in the pursuit of transformative therapies and medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cambridge, Massachusetts, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported